![Gerald W. St. Peter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gerald W. St. Peter
Directeur Général chez
PolyActiva Pty Ltd.
Profil
Gerald W.
St. Peter was the founder of Eyevance Pharmaceuticals LLC, serving as Chief Executive Officer in 2017.
Mr. St. Peter is the founder of PolyActiva Pty Ltd., serving as Chief Executive Officer & Director starting in 2025.
Former jobs include Chief Executive Officer & Director at Xequel Bio, Inc., President, Chief Executive Officer & Director at Eyevance Pharmaceuticals Holdings, Inc., National Sales Director at MURO Pharmaceuticals, Inc., Senior Vice President-Sales at Inspire Pharmaceuticals, Inc. from 2003 to 2010, and Executive Vice President at Nicox SA. Education includes an undergraduate degree from the University of Massachusetts.
Postes actifs de Gerald W. St. Peter
| Sociétés | Poste | Début |
|---|---|---|
PolyActiva Pty Ltd.
 PolyActiva Pty Ltd. BiotechnologyHealth Technology Operates as a clinical-stage ophthalmology company that develops drug-polymer conjugate technology | Directeur Général | 18/06/2025 |
Anciens postes connus de Gerald W. St. Peter
| Sociétés | Poste | Fin |
|---|---|---|
Eyevance Pharmaceuticals Holdings, Inc.
 Eyevance Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops and commercializes topical ophthalmic products | Directeur Général | - |
Eyevance Pharmaceuticals LLC
 Eyevance Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Fondateur | - |
Xequel Bio, Inc.
 Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration | Directeur Général | - |
| NICOX SA | Corporate Officer/Principal | - |
MURO Pharmaceuticals, Inc.
 MURO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals; allergy and asthma products | Sales & Marketing | - |
Formation de Gerald W. St. Peter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Inspire Pharmaceuticals, Inc.
 Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Health Technology |
Xequel Bio, Inc.
Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration | Health Technology |
Nicox SA
 Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals | Health Technology |
MURO Pharmaceuticals, Inc.
MURO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals; allergy and asthma products | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PolyActiva Pty Ltd.
PolyActiva Pty Ltd. BiotechnologyHealth Technology Operates as a clinical-stage ophthalmology company that develops drug-polymer conjugate technology | Health Technology |
Eyevance Pharmaceuticals LLC
Eyevance Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Health Technology |
Eyevance Pharmaceuticals Holdings, Inc.
Eyevance Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops and commercializes topical ophthalmic products | Health Technology |
